首页> 美国卫生研究院文献>Proceedings (Baylor University. Medical Center) >Hyperammonemic encephalopathy associated with 5-fluorouracil in a patient with previous orthotopic liver transplantation
【2h】

Hyperammonemic encephalopathy associated with 5-fluorouracil in a patient with previous orthotopic liver transplantation

机译:曾接受原位肝移植的患者伴有5-氟尿嘧啶的高氨血症性脑病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

5-Fluorouracil (5-FU)–based chemotherapy is the most common regimen used to treat metastatic or advanced colon cancer. Neurotoxicity is a rare but serious adverse effect of 5-FU–based therapy. We report an unusual case of 5-FU–induced hyperammonemic encephalopathy in a patient with recurrent colon cancer that metastasized to the liver and lung. Two days after receiving the third dose of FOLFOX, he presented with altered mental status, agitation, abdominal pain, nausea, and vomiting. His total ammonia level was 434 μmol/L, for which he was treated with lactulose retention enema and lactulose via nasogastric tube. Over the next 24 hours, his condition improved significantly.
机译:基于5-氟尿嘧啶(5-FU)的化学疗法是用于治疗转移性或晚期结肠癌的最常见方案。神经毒性是基于5-FU的治疗的罕见但严重的不良反应。我们报告了一名复发性结肠癌患者转移至肝和肺的5-FU引起的高氨血症性脑病的罕见病例。在接受第三剂FOLFOX后两天,他出现了精神状态改变,躁动,腹痛,恶心和呕吐。他的总氨水平为434μmol/ L,为此他经鼻胃管用乳果糖保留灌肠剂和乳果糖治疗。在接下来的24小时内,他的病情明显好转。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号